Condition
PTEN Hamartoma Syndrome
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06805734RecruitingPrimary
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
NCT04094675Phase 2Completed
Sirolimus for Cowden Syndrome With Colon Polyposis
NCT06712095Not ApplicableRecruiting
Video Capsule Examination in Patients With Lynch Syndrome
NCT06080165Phase 1Withdrawn
Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Showing all 4 trials